Evidence for a similar role for these hormones in man was sought by using a radioreceptor assay to measure plasma 1,25(0H),D, concentrations in 20 normal subjects, 12 patients receiving dialysis, 11 patients with primary hyperparathyroidism, 10 pregnant women, seven women with prolactinoma, and 14 patients with acromegaly.
Introduction
Renal regulation of vitamin D metabolism has been controversial, but the concept of parathyroid hormone as the only important regulatory factor is now clearly completely untenable.' Considerable evidence indicates that the increased calcium demands made during physiological conditions of calcium stress, such as pregnancy, lactation, and growth, are met by increased production of 1,25-dihydroxycholecalciferol (1, 25 
Results
The figure shows the results in the different groups of subjects. The mean ± SE of mean plasma 1,25(OH)2D3 concentration in normal subjects was 29-4±1-9 ng/l; in patients with chronic renal failure receiving dialysis < 10 ng/l; in patients with primary hyperparathyroidism 550 ±5-5 ng/l (P <0-001); in pregnant women 87-7 ± 11-2 ng/l (P < 0-001); in patients with prolactinomas 40 4 43-25 ng/l (P < 0 05); and in patients with acromegaly 47-7 ±4-6 ng/l (P < 0 001). figure) . This-fits well with the idea that parathyroid hormone has two effects: to stimulate production of the active metabolite by the kidney; and to increase plasma calcium concentrations by an independent action to enhance renal tubular calcium resorption. Clearly sometimes the increased calcium concentration will exert a powerful depressing effect on 1,25(OH)2D, synthesis outweighing the direct stimulatory effect of parathyroid hormone. This agrees closely with earlier experimental findings and concepts. 8 The most striking changes seen were in pregnancy, when all values were above the normal range. These results agree well with those of other workers2 9 and provide a satisfactory explanation for the increased calcium absorption that occurs in pregnant animals and women. The factors responsible for the increased concentrations of 1,25(OH)2D,, however, are not yet known, although parathyroid hormone, oestrogen, prolactin, and placental lactogen, which are all raised at some stage of pregnancy, are known or proposed regulators of renal vitamin D metabolism.
Plasma concentrations of parathyroid hormone start to rise after the 36th week of pregnancy,10 but our results show extremely high plasma 1,25(OH)2D, concentrations before this.
In contrast, plasma concentrations of oestrogen, prolactin, and placental lactogen are raised during early human pregnancy. Oestrogens are potent stimulators of renal 25-hydroxy vitamin DI, 1 -hydroxylase (25-OHD,-1 a-hydroxylase) in birds," although studies in man have shown that exogenous administration of oestrogen does not increase calcium absorption.12 Prolactin also stimulates production of 1,25(OH)2D, in birds,3 and studies with bromocriptine in lactating rats13 suggest that it may have a similar effect in mammals in the proper physiological setting. Similarly, placental lactogen stimulates 25-OHD,-lxhydroxylase activity in birds (E Spanos, unpublished work) and enhances calcium absorption in mammals.'4 Thus the pituitary and placental hormones, rather than the parathyroid hormone, are the probable regulators in pregnancy.
Interestingly, the plasma concentrations in patients with prolactinoma were only slightly, though significantly (P <0 05), increased. There is no correlation between plasma concentrations of 1,25(OH)2D3 and prolactin. Clearly the effects of prolactin shown only in lactation in animals are not important in prolactinoma, though are likely to be relevant during pregnancy.
The significantly increased (P <0001) circulating 1,25(OH) 2D3 concentrations in patients with acromegaly explain the altered calcium metabolism in this condition and strongly suggest that growth hormone stimulates production of 1,25(OH),D3 in man as it does in the rat.4 The wide range of values and the lack of correlation between plasma concentrations of 1,25(OH)2D, and growth hormone, however, indicate that other factors, perhaps including the stage of the disease, are important.
Thus the main physiological role of 1,25(OH) 2D, appears to be enhancing absorption when extra calcium and phosphorus are needed. This is mainly during growth, pregnancy, and lactation, and 1,25(OH)2D, may perhaps best be regarded as a hormone whose most vital role is to provide the calcium and phosphorus requirements of the fetus and growing child. These concepts were developed from earlier work in experimental animals,' but our studies show that they are probably also valid in man. The pituitary hormones are probably very important in these conditions, although placental lactogen and oestrogen may also play a part during pregnancy and parathyroid hormone in lactation. In any event, early disagreements about regulation seem resolved with the recognition of the multifactorial nature of the control of vitamin D metabolism.
